Renewal of the approval of the active substance
Article 1
Open ↗The approval of the active substance acetamiprid is renewed as set out in Annex I.
Commission Implementing Regulation (EU) 2018/113 of 24 January 2018 renewing the approval of the active substance acetamiprid in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance. )
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Renewal of the approval of the active substance
The approval of the active substance acetamiprid is renewed as set out in Annex I.
Amendments to Implementing Regulation (EU) No 540/2011
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.
Entry into force and date of application
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 1 March 2018.
ANNEX I Common Name, Identification Numbers IUPAC Name Purity ( 1 ) Date of approval Expiration of approval Specific provisions Acetamiprid CAS No 135410-20-7 CIPAC No 649 (E)-N1-[(6-Chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine ≥ 990 g/kg 1 March 2018 28 February 2033 For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on acetamiprid, and in particular Appendices I and II thereof, shall be taken into account. In their overall assessment Member States shall pay particular attention to: — the risk to aquatic organisms, bees and other non-target arthropods, — the risk to birds and mammals, — the risk to consumers, — the risk to operators. Conditions of use shall include risk mitigation measures, where appropriate. ( 1 ) Further details on identity and specification of active substance are provided in the renewal report.
ANNEX II The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in Part A, entry 91 on acetamiprid is deleted; (2) in Part B, the following entry is added: Number Common Name, Identification Numbers IUPAC Name Purity ( 1 ) Date of approval Expiration of approval Specific provisions ‘119 Acetamiprid CAS No 135410-20-7 CIPAC No 649 (E)-N1-[(6-Chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine ≥ 990 g/kg 1 March 2018 28 February 2033 For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on acetamiprid, and in particular Appendices I and II thereof, shall be taken into account. In their overall assessment Member States shall pay particular attention to: — the risk to aquatic organisms, bees and other non-target arthropods, — the risk to birds and mammals, — the risk to consumers, — the risk to operators. Conditions of use shall include risk mitigation measures, where appropriate.’ ( 1 ) Further details on identity and specification of active substance are provided in the renewal report.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.